media - FDA OKs sixth gadolinium-based MRI contrast agent (also known as Gadavist/Gadovist) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, March 17, 2011

media - FDA OKs sixth gadolinium-based MRI contrast agent (also known as Gadavist/Gadovist)



Gadavist, known as Gadovist

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.